Canada Markets closed
  • S&P/TSX

    20,490.36
    -111.74 (-0.54%)
     
  • S&P 500

    4,432.99
    -40.76 (-0.91%)
     
  • DOW

    34,584.88
    -166.44 (-0.48%)
     
  • CAD/USD

    0.7840
    -0.0047 (-0.5903%)
     
  • CRUDE OIL

    71.96
    -0.65 (-0.90%)
     
  • BTC-CAD

    60,355.28
    -567.60 (-0.93%)
     
  • CMC Crypto 200

    1,197.55
    -27.98 (-2.28%)
     
  • GOLD FUTURES

    1,752.00
    -4.70 (-0.27%)
     
  • RUSSELL 2000

    2,236.87
    +3.96 (+0.18%)
     
  • 10-Yr Bond

    1.3700
    +0.0390 (+2.93%)
     
  • NASDAQ

    15,043.97
    -137.96 (-0.91%)
     
  • VOLATILITY

    21.13
    +2.44 (+13.06%)
     
  • FTSE

    6,963.64
    -63.84 (-0.91%)
     
  • NIKKEI 225

    30,500.05
    +176.71 (+0.58%)
     
  • CAD/EUR

    0.6682
    -0.0016 (-0.24%)
     

How Good Were Celldex Therapeutics' Latest Clinical Results?

·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

In this Motley Fool Live video recorded on July 14, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss just how good the biotech's latest clinical results were. Keith Speights: Let's talk about a small biotech that really hasn't been in the news much until just recently.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting